Extended Release Bupivacaine Hydrochloride Resorbable Matrix Formulation

An extended release (ER) injectable formulation composed of the hydrochloride salt form of bupivacaine, an amide-type, long-acting local anesthetic, in a resorbable sucrose acetate isobutyrate-based matrix, with analgesic activity. Following administration in or around a specific site, ER bupivacaine is released from the matrix over an extended period of time. Upon release, bupivacaine reversibly binds to specific voltage-gated sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions, membrane destabilization, and depolarization inhibition thus disrupting nerve impulse conduction. This eventually leads to a reversible loss of sensation. This formulation may provide pain relief up to 72 hours. (NCI Thesaurus)

YOU MAY ALSO LIKE

Extended Release Bead Implant Dosage Form

A solid in the shape of a small sphere intended to be embedded securely in the body and designed to release active…

Extended Fetal Attitude

A position of the fetus during the labor and delivery process where the head is extended back.

Extendable Class

Abstract class that specifies for subclasses an association to NameValueTypes. These can be used, for instance, to specify proprietary properties and…

Extend

To increase in length or duration.

EXT2 wt Allele

Human EXT2 wild-type allele is located within 11p12-p11 and is approximately 150 kb in length. This allele, which encodes exostosin-2 protein, plays…

EXT2 Gene

This gene is involved in the heparin/heparin sulfate biosynthesis, cell organization/biogenesis and development of the cytoskeleton in chondrocytes.